SCHEMBL13556842

SCHEMBL13556842

c1ccc(-c2ccc(-n3c4cccnc4c4c5ccccc5c5c(c6ccccc6c6c7ncccc7n(-c7ccc(-c8ccccc8)cc7)c65)c43)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MMP2 P08253 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KMT2A Q03164 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ PDE4A P27815 4/20 0.35
▸ PDE4B Q07343 4/20 0.35
▸ PDE4C Q08493 4/20 0.35
▸ PDE4D Q08499 4/20 0.35
▸ HTR2A P28223 1/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ FEN1 P39748 1/20 0.33
▸ SIRT2 Q8IXJ6 1/20 0.33
▸ MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13556854 0.93 ALDH1A1 (0.36) TSHRALDH1A1CYP2C19MMP2KDM4E
SCHEMBL13556831 0.91 KDM4E (0.44) TSHRALDH1A1CYP2C19KDM4EATM
SCHEMBL13556859 0.89 ALDH1A1 (0.34) TSHRALDH1A1CYP2C19MMP2KDM4E
SCHEMBL13556849 0.89 NR3C1 (0.36) TSHRALDH1A1CYP2C19MMP2KDM4E
SCHEMBL13556858 0.87 MTOR (0.39) TSHRALDH1A1MMP2KDM4EL3MBTL1
SCHEMBL13556853 0.87 NR3C1 (0.34) TSHRALDH1A1CYP2C19MMP2KDM4E
SCHEMBL13556836 0.85 PDE4A (0.34) TSHRALDH1A1CYP2C19KDM4EATM
SCHEMBL13556845 0.84 ALK (0.38) TSHRALDH1A1MMP2KDM4EL3MBTL1
SCHEMBL18057797 0.83 L3MBTL1 (0.41) TSHRALDH1A1CYP2C19MMP2KDM4E
SCHEMBL18057737 0.83 L3MBTL1 (0.41) TSHRALDH1A1CYP2C19MMP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889270-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2014-11-18 — — US disclosed
US-8889270-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2014-11-18 — — US disclosed
US-20120267613-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2012-10-25 — — US disclosed
US-20120267613-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2012-10-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120267613-A1 ORGANIC LIGHT-EMITTING DEVICE CRY1, CYP1A1, CRY2 TSHR 2308/4885ALDH1A1 6/4885CYP2C19 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback